Sobrerol

DB13315InvestigationalSmall molecule

Sobrerol is a mucolytic indicated in patients with chronic respiratory diseases. A medication used to clear mucus from the lungs and throat in patients with long term lung or breathing disorders.

Formula / weight: C₁₀H₁₈O₂ · 170.252 g/mol (avg)

Resolves to

Compound

UNII7WJQ6A6U4WCAS42370-41-2ChEMBLCHEMBL2374961

Clinical / RWD

RxNorm36669ATCR05CB07

Structure

InChIKeyOMDMTHRBGUBUCO-BDAKNGLRSA-NSMILESCC1=CC[C@H](C[C@@H]1O)C(C)(C)O

What you can answer from here — as of April 02, 2025

4Structured indicationsCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

56Marketed productsAcross 3 countries and 7 labellers

1ATC codeIncluding every combination product, plus 3 drug categories

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Sobrerol, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account